Medtronic's High Dividend Yield Gets Little Attention on Wall Street -- Should You Buy the Stock Anyway?
The medical device giant grew its top line by a double-digit percentage in the first quarter of its fiscal 2027.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.